Skip to results
1-11 of 11
Authors: Yoon-Koo Kang
Sort by
Journal Article
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy Open Access
Suzanne George and others
The Oncologist, Volume 26, Issue 4, April 2021, Pages e639–e649, https://doi.org/10.1002/onco.13674
Published: 01 February 2021
Journal Article
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors Open Access
Cissimol P. Joseph and others
The Oncologist, Volume 26, Issue 4, April 2021, Pages e622–e631, https://doi.org/10.1002/onco.13632
Published: 05 January 2021
Journal Article
Systemic Steroid Treatment for Imatinib‐Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study Free
Eo Jin Kim and others
The Oncologist, Volume 25, Issue 11, November 2020, Pages e1785–e1793, https://doi.org/10.1634/theoncologist.2019-0953
Published: 12 July 2020
Journal Article
Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses Open Access
Hyungwoo Cho and others
The Oncologist, Volume 24, Issue 12, December 2019, Pages e1443–e1449, https://doi.org/10.1634/theoncologist.2019-0009
Published: 17 July 2019
Journal Article
Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib Free
Jae‐Joon Kim and others
The Oncologist, Volume 24, Issue 11, November 2019, Pages e1212–e1218, https://doi.org/10.1634/theoncologist.2019-0033
Published: 29 April 2019
Journal Article
A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer Free
Min‐Hee Ryu and others
The Oncologist, Volume 22, Issue 2, February 2017, Pages 129–e8, https://doi.org/10.1634/theoncologist.2016-0273
Published: 18 September 2017
Journal Article
A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction Free
Manish A. Shah and others
The Oncologist, Volume 21, Issue 9, September 2016, Pages 1085–1090, https://doi.org/10.1634/theoncologist.2016-0038
Published: 08 July 2016
Journal Article
A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group Free
Tae Min Kim and others
The Oncologist, Volume 19, Issue 11, November 2014, Pages 1129–1130, https://doi.org/10.1634/theoncologist.2014-0305
Published: 03 October 2014
Journal Article
Quality of Life in the Trastuzumab for Gastric Cancer Trial Free
Taroh Satoh and others
The Oncologist, Volume 19, Issue 7, July 2014, Pages 712–719, https://doi.org/10.1634/theoncologist.2014-0058
Published: 20 June 2014
Journal Article
Kinase Mutations and Efficacy of Imatinib in Korean Patients with Advanced Gastrointestinal Stromal Tumors Free
Tae Won Kim and others
The Oncologist, Volume 14, Issue 5, May 2009, Pages 540–547, https://doi.org/10.1634/theoncologist.2008-0145
Published: 02 May 2009
Journal Article
Clinical Reversal of Multidrug Resistance Free
Susan E. Bates and others
The Oncologist, Volume 1, Issue 4, August 1996, Pages 269–275, https://doi.org/10.1634/theoncologist.1-4-269
Published: 01 August 1996
Advertisement
Advertisement